D.A. Davidson & Co. Repligen Corp Transaction History

D.A. Davidson & Co.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 31, 2022	SELL	$247.59 - $304.47 $287,204 - $353,185	-1,160 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$194.77 - $324.21 $194 - $324	-1 Reduced 0.09%	1,160 $335,000
Q2 2021 Aug 10, 2021	SELL	$165.87 - $220.95 $3,317 - $4,419	-20 Reduced 1.69%	1,161 $232,000
Q1 2021 May 07, 2021	BUY	$180.37 - $226.26 $213,016 - $267,213	1,181 New	1,181 $230,000

522

53.2M

1.05M

228K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.7B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

Stay updated on D.A. Davidson & Co. with notifications on news.